Status:
COMPLETED
Elizabeth Registry for Low Grade Ovarian Cancer
Lead Sponsor:
M.D. Anderson Cancer Center
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
Brief Summary
Long-Term Objectives: * To establish an ongoing national research registry of epidemiologic, clinical and pathologic data on low grade and low malignant potential (LMP) ovarian cancer patients in UTM...
Detailed Description
The Registry will be an ongoing research registry that will include patients who have been diagnosed with low grade ovarian, primary peritoneal or fallopian tube or low malignant potential (LMP) ovari...
Eligibility Criteria
Inclusion
- UTMDACC patient, living or deceased, with a pathologically-confirmed diagnosis of either low grade ovarian carcinoma or LMP ovarian carcinoma.
- Able to speak and read English (for patients who are living).
- Residence in the United States, both at time of original diagnosis and at time of accession to the Registry.
Exclusion
- UTMDACC patients, living or deceased, whose diagnosis of either low grade ovarian carcinoma or LMP ovarian carcinoma has not been confirmed pathologically.
- Any type of ovarian cancer other than low grade or LMP ovarian carcinoma.
- Unable to speak and read English (for patients who are living).
- Residence outside the United States, either at time of original diagnosis or at time of accession to the Registry.
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00345709
Start Date
September 1 2003
End Date
October 1 2014
Last Update
October 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030